Product NDC: | 16729-140 |
Proprietary Name: | Glipizide |
Non Proprietary Name: | glipizide |
Active Ingredient(s): | 10 mg/1 & nbsp; glipizide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16729-140 |
Labeler Name: | Accord Healthcare Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074550 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110301 |
Package NDC: | 16729-140-00 |
Package Description: | 100 TABLET in 1 BOTTLE (16729-140-00) |
NDC Code | 16729-140-00 |
Proprietary Name | Glipizide |
Package Description | 100 TABLET in 1 BOTTLE (16729-140-00) |
Product NDC | 16729-140 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | glipizide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110301 |
Marketing Category Name | ANDA |
Labeler Name | Accord Healthcare Inc. |
Substance Name | GLIPIZIDE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |